Ep 4: Ketamine: The Good, The Bad, The Future of Treating Depression?

Eyewitness Beauty

0:00

Current time: 0:00 / Total time: -47:27

-47:27

Paid episode

The full episode is only available to paid subscribers of Eyewitness Beauty

Ep 4: Ketamine: The Good, The Bad, The Future of Treating Depression?

June 26, 2020

Eyewitness Beauty

Jul 03, 2020

∙ Paid

Annie and Nick speak with Dr. Robert Meisner, MD, medical director of McLean Hospital's Ketamine Service and a clinical fellow in psychiatry at Harvard Medical School, about the new frontier of depression treatment using the synthetic drug ketamine. Plus, they discuss the misuse of ketamine as a sedating agent by first responders, and the worrying menta…

Listen to this episode with a 7-day free trial

Subscribe to Eyewitness Beauty to listen to this post and get 7 days of free access to the full post archives.

Eyewitness Beauty

To hear full new episodes and to browse our four-year archive, subscribe to our Substack at eyewitnessbeauty.substack.com (https://eyewitnessbeauty.substack.com/) .

“My favorite podcast.” — Emily Sundberg, Feed Me (https://www.readfeedme.com/)

“This one’s for the Into The Gloss (https://intothegloss.com/) Day Ones.” — Vogue

Brand founders, beauty editors, and creative-types Annie Kreighbaum (Glossier, Soft Services) and Nick Axelrod-Welk (Into The Gloss, Nécessaire) discuss industry news, start-up culture, and pop culture in their (mostly) weekly podcast, Eyewitness Beauty.

Listen on